"Complexio und coniunctio oppositorum" der griechischen Heilgötter Apollon und Asklepios.

Stefenelli T.

Österr. Ärzteztg. 1985; 40: 61-64.

 

Cardial decompensation caused by hypertension and polyglobulia associated with multiple renal oncocytomas.

Stefenelli T, Silberbauer K, Ulrich W, Sommeregger K, Zechner O.

Clin. Nephrol. 1985; 23: 307-311.

 

Vibrationssyndrom - Fallbericht eines Metallschleifers.

Stefenelli T, Silberbauer K, Harmuth P, Jahn O.

VASA 1986; 15: 81-84.

 

Die "Allegorie auf den Arzt" von H. Golzius.

Stefenelli T.

Österr. Ärzteztg. 1986; 41: 38-40.

 

Das Vibrationssyndrom aus orthopädischer Sicht.

Engel A, Lack W, Stefenelli T, Harmuth P, Wimberger D.

Orthop. Praxis 1987; 23: 246-251.

 

Rehabilitation älterer Patienten mit peripherer arterieller Verschlußkrankheit und Zustand nach Unterschenkelamputation.

Stefenelli T, Engel A, Bachl N, Kelaridis T, Mannheimer E.

VASA 1987; 16: 373-376.

 

Myocardial ischaemia with angiographically normal coronary arteries: pointers to a vasospastic genesis.

Stefenelli T, Glogar D, Sochor H, Czernin J, Probst P.

Deut. Med. Wochenschr. 1987.112: 1580-1583.

 

Beeinflussung von Anfallshäufigkeit und Wiedererwärmungszeit durch Pentoxiphyllin/Placebo/Nifedipin bei Patienten mit Raynaud Phänomen.

Stefenelli T, Silberbauer K, Glogar D.

In: Fortschritte in der kardiovaskulären Hämorheologie, Hrg. Strauer BE, Ehrly AH, Leschke M; Münchner wissenschaftliche Publikationen, 1987: 88-90.

Klin. Wochenschr. 1986; 64: 1155-6.

 

Increase of pulmonary vascular resistance during cold provocation in patients with variant angina.

Stefenelli T, Glogar D, Dvorak I, Sochor H.

Int. J. Cardiol. 1988; 18: 27-33.

 

Maligne Rhythmusstörungen (Kammerflimmern, AV-Block III) bei Patienten mit vasospastischer angina.

Stefenelli T, Glogar D.

Int. Praxis 1988; 28: 17-22.

 

Maligne Rhythmusstörungen bei Patienten mit Prinzmetal angina.

Stefenelli T, Glogar D.

Tägl. Praxis 1988; 29: 1-6.

 

Blood pressure and erythropoietin.

Mayer G, Stefenelli T, Cada EM, Thum J, Stummvoll HK, Graf H.

Lancet 1988; I: 351-352 (Letter).

 

Acute vascular toxicity after combination chemotherapy with cisplatin, vinblastine, and bleomycin for testicular cancer.

Stefenelli T, Kuzmits R, Ulrich W, Glogar D.

Eur. Heart J. 1988; 9: 552-556.

 

In vitro evaluation of the anticancer drug modulatory effect of hyaluronidase in human gastrointestinal adenocarcinoma cell lines.

Scheithauer W, Temsch EM, Stefenelli T, Lathan B.

Anticancer Res. 1988; 8: 391-398.

 

Results of experimental studies of the modulating effect of hyaluronidase on cytostatics in gastrointestinal carcinoma cell lines.

Scheithauer W, Temsch EM, Stefenelli T, Lathan B.

Wien. Klin. Wochenschr. 1988; 100 (Suppl.178): 12-13.

 

Der Archetyp des heilenden Gottes. Eine geschichtlich-kulturelle Betrachtung und seine mögliche Bedeutung für die Arzt-Patient Beziehung.

Stefenelli T.

In: Die Arzt-Patient Beziehung. Ausgewählte Aspekte; Hrg: Ringel E, Rossmanith S; Maudrich

Verlag, Wien, 1988: 19-30.

 

Prinzmetal's angina during cyclophosphamide.

Stefenelli T, Zielinski CC, Mayr H, Scheithauer W.

Eur. Heart J. 1988; 9: 1155-1157.

 

Magnesium profile in vasospatic angina.

Stefenelli T, Huber K, Sochor H, Smetana R, Probst P.

Magnesium-Bull. 1989; 11: 99-102.

 

Humoral regulation during cold provoation in patients with vasospastic angina.

Stefenelli T, Sinzinger H, Sochor H, Glogar D, Kaliman J.

Int. J. Cardiol. 1989; 25: 199-205.

 

Influence of positive inotropic agents on intracellular calcium transients, Part I. Normal rat heart.

Aufferman W, Stefenelli T, Wikman-Coffelt J, Wu ST, Parmley WW, Mason DT.

Am. Heart J. 1989; 118: 1219-1227.

 

Influence of positive inotropic agents on intracellular calcium transients, Part II. Cardiomyopathic hamster hearts.

Stefenelli T, Wu ST, Parmley WW, Mason DT, Wikman-Coffelt J.

Am. Heart J. 1989; 118: 1228-1236.

 

Angiologische, neurologische und orthopädische Befunde bei vibrationsexponierten Kettensägenarbeitern.

Stefenelli T, Wimberger D, Harmuth P, Engel A, Lack W, Samec P, Silberbauer K.

Wien. Klin. Wochenschr. 1990; 102: 24-27.

 

Plasminogen activator inhibitor-1 levels in patients with chronic angina pectoris with or without angiographic evidence of coronary sclerosis.

Huber K, Resch I, Stefenelli T, Lang I, Probst P, Kaindl F, Binder BR.

Thromb. Haemostasis 1990; 63: 336-339.

 

Heart transplantation: indication, selection criteria and patient management.

Glogar D, Pacher R, Stefenelli T, Weidinger F, Laczkovics A, Kaindl F.

Wien. Med. Wochenschr. 1990;140:287-9.

 

 

Calcium-dependent fluorescence transients during ventricular fibrillation.

Stefenelli T, Wikman-Coffelt J, Wu ST, Parmley WW.

Am. Heart J. 1990; 120: 590-597.

 

Cardiac calcific deposits in patients with primary hyperparathyeoidism: preliminary results of a prospective echocardiographic study.

Niederle B, Stefenelli T, Mayr H, Glogar D, Roka R, Woloszczuk W.

Surgery 1990; 108: 1052-1057.

 

Digital vascular reactivity in patients on haemodialysis treated with human recombinant erythropoietin.

Stefenelli T, Boszotta A, Mayer G, Graf H.

VASA 1991; 20: 70-73.

 

Positive inotropic substances in therapy of heart failure.

Stefenelli T.

Acta Med. Austriaca 1991; 18: 81-5.

 

 [Ca2+]i transients in the cardiomyopathic hamster heart.

Wikman-Coffelt J, Stefenelli T, Wu ST, Parmley WW, Jasmin G.

Circulation Res. 1991; 68: 45-51.

 

 [Ca²⁺]i during pacing-induced ventricular fibrillation, ventricular tachycardia, and lidocaine treatment.

Stefenelli T, Wu ST, Wikman-Coffelt J, Parmley WW.

J. Am. Coll. Cardiol. 1991; 17: 249A.

 

48h-Langzeit-EKG-Dokumentation bei Patienten mit vasospastischer Angina pectoris.

Rimpfl T, Stefenelli T, Weber H, Kaindl F.

CorVas, 1991; 3: 143-147.

 

Myelosakom des Ovars.

Stefenelli T, Linkesch W, Radaszciewics T.

Wien. Klin. Wochenschr. 1991; 103: 717-718.

 

Transient myocardial perfusion abnormalities during cold provocation test in patients with arterial hyperreactivity.

Stefenelli T, Sochor H, Slama B, Czernin J, Pachinger O, Probst P.

Z. Kardiol. 1991; 80: 622-626.

 

Parathyroid hormone and calcium behavior in advanced congestive heart failure.

Stefenelli T, Pacher R, Woloszczuk W, Glogar D, Kaindl F.

Z. Kardiol. 1992; 81: 121-125.

 

Heart rate behaviour at different stages of congestive heart failure.

Stefenelli T, Bergler-Klein J, Globits S, Pacher R, Glogar D.

Eur. Heart J. 1992; 13: 902-907.

 

Intracellular calcium during pacing-induced ventricular fibrillation: effects of lidocaine.

Stefenelli T, Wu ST, Wikman-Coffelt J, Parmley WW.

J. Electrocardiol. 1992; 25: 221-228.

 

Myocardial calcinosis in a juvenile patient with Wermer syndrome (multiple endocrine neoplasia type I).

Stefenelli T, Globits S, Kratochwill Ch, Vierhapper H, Niederle B.

Wien. Klin. Wochenschr.1992; 104: 698-700.

 

Pimobendan (UDCG 115 BS) in the long-term treatment of congestive heart failure. 

Bergler-Klein J, Globits S, Stefenelli T, Mayr H, Porenta G, Sochor H, Glogar D.

Z. Kardiol. 1992; 81: 546-552.

 

Effects of propafenone on pacing-induced ventricular fibrillation and intracellular calcium in rat hearts.

Stefenelli T, Wu ST, Parmley WW, Wikman-Coffelt J.

Eur. Heart J. 1992; 13: 1556-1561.

 

Tachykardieinduzierte Herzinsuffizienz: Normalisierung der Linksventrikelfunktion nach Konversion von rasch übergeleitetem Vorhofflimmern in Sinusrhythmus.

Stefenelli T, Globits S, Probst P.

Herz/Kreisl. 1993; 25: 114-116.

 

Primary hyperparathyroidism. Incidence and significance of cardiac abnormalities and partial recovery after successful parathyroidectomy.

Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B.

Am. J. Med. 1993; 95: 197-202.

 

Cardiac changes in patients with hypercalcemia.

Stefenelli T, Globits S, Bergler-Klein J, Wolozczuk W, Längle F, Niederle B.

Wien. Klein. Wochenschr. 1993;105:339-41.

 

Kardiologische Abklärung vor einer Nierentransplantation.

Stefenelli T, Hörl WH, Maurer G.

Österr. Ärzteztg. 1994; 12: 57.

 

Primary hyperparathyroidism and the heart: Cardiac abnormalities correlated to clinical and biochemical data.

Längle F, Abela C, Koller-Strametz J, Mittelböck M, Bergler-Klein J, Stefenelli T, Woloszczuk W, Niederle B.

World J. Surg. 1994; 18: 619-624.

 

Implantable cardioverter-defibrillator dysfunction after coronary artery bypass grafting.

Geppert A, Bankier AA, Maurer G, Stefenelli T.

Am. J. Cardiol. 1995; 76: 742-743.

 

Effect of ischemic preconditioning and lidocaine pretreatment on [Ca2+]i in rat hearts.

Stefenelli T, Wu ST, Zaugg CP, Smith G, Wikman-Coffelt J, Parmley WW.

J. Am. Coll. Cardiol. 1995; 25: 28-9A.

 

Rapid adaptation of myocardial calcium homeostasis to short episodes of ischemia in isolated rat hearts.

Smith GB, Stefenelli T, Wu ST, Wikman-Coffelt J, Parmley WW, Zaugg CE.

Am. Heart J. 1996; 131: 1106-1112.

 

Urinary excretion of Apo(a) fragments: Role of Apo(a) catabolism.

Kostner K, Maurer G, Huber K, Stefenelli T. Dieplinger H, Steyrer E, Kostner GM.

Arterioscler. Thromb. Vasc. Biol. 1996; 16: 905-911.

 

Atypical elevation of creatine kinase and -isoenzyme (CK-MB) levels in a patient with mitral valve disease.

Hoffman U, Kurek C, Kostner K, Scholten C, Clodi M, Lang I, Stefenelli T.

Eur. Heart J. 1996; 17: 1764-1765.

 

Assessment of myocardial injury by serum tumor necrosis factor alpha measurements in acute myocardial infarction.

Hirschl M, Gwechenberger M, Binder T, Binder M, Graf S, Stefenelli T, Rauscha F, Laggner AN, Sochor H.

Eur. Heart J. 1996; 17: 1852-1859.

 

 

Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up.

Stefenelli T, Abela C, Frank H, Koller-Strametz J, Globits S, Bergler-Klein J, Niederle B.

J. Clin. Endocrinol. Metabol. 1997; 82: 106-112.

 

Time course of regression of left ventricular hypertrophy after successful parathyroidectomy.

Stefenelli T, Abela C, Frank H, Koller-Strametz J, Niederle B.

Surgery 1997; 121: 157-161.

 

Urinary apo(a) discriminates coronary artery disease patients from controls.

Kostner K, Huber K, Stefenelli T, Rinner H, Maurer G.

Atherosclerosis 1997; 129: 103-110.

 

Urinary excretion of Apo(a) in patients with kidney transplantation.

Kostner K, Oberbauer R, Hoffmann U, Stefenelli T, Maurer G, Watschinger B.

Nephrol. Dial. Transpl. 1997; 12: .

 

A novel therapeutic strategy for the management of idiopathic chylopericardium.

Scholten C, Staudacher M, Girsch W, Wolf , Grimm W, Binder T, Lang I, Stefenelli T.

Surgery 1998; 123: 369-370.

 

Impairment of endothelium-independent vasodilation in patients with hypercalcemia.

Neunteufel T, Katzenschlager R, Abela C, Kostner K, Niederele B, Weidinger F, Niederle B, Stefenelli T.

Cardiovasc. Res. 1998; 40: 396-401.

 

"Overestimation" of catheter gradients by Doppler ultrasound in patients with aortic stenosis - a predictable manifestation of pressure recovery.

Baumgartner H, Stefenelli T, Niederberger J, Schima H, Maurer G.

J. Am. Coll. Cardiol. 1999; 33: 1655-1661.

 

Calcium antagonists a round table discussion on dihydropyridines in an epicurean environment.

Opie LH, Stefenelli T, Gasser R.

J. Clin. Basic Cardiol. 1999; 2: 1-2.

 

Accumulation of oxidized LDL in human semilunar valves correlates with coronary atherosclerosis.

Mehrabi MR, SinzingerH, Ekmekcioglu C, Tamaddon F, Plesch K, Glogar HD, Maurer G, Stefenelli T, Lang I.

Cardiovasc. Res. 2000; 45: 874-882.

 

Effects of successful parathyroidectomy on altered arterial reactivity in patients with hypercalcaemia: results of a 3-year follow-up study.

Neunteufel T, Heher S, Prager G, Katzenschlager R, Abela C, Niederele B, Stefenelli T.

Clin. Endocrinol. 2000; 53: 229-233.

 

Response of right ventricular function to prostaglandin E1 infusion predicts outcome for severe chronic heart failure patients awaiting urgent transplantation.

Hülsmann M, Stefenelli T, Berger R, Sturm B, Parkner A, Zuckermann A, Woloszczuk W, Pacher R.

J. Heart Lung Transplant. 2000; 19: 939-945.

 

Valsartan in acute myocardial infarction trial (VALIANT): rationale and design.

Pfeffer MA, McMurray J, Leizorovicz A, Maggioni AP, Rouleau J-L, Van de Werf F, Henis M, Neuhart E, Gallo P, Edwards S, Sellers MA, Velazquez E, Califf R, for the VALIANT Investigators.

Am. Heart J. 2000; 140: 727-734.

 

Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy

Schmid A, Stefenelli T, Schuster E, Mayer G.

Am. J. Kidney Dis. 2001; 37: 56-63.

 

Emergency angioplasty and stent deployment for acute occlusion of an anomalous single coronary artery (All three coronary arteries  from one ostium in the right sinus of Valsalva).

Stefenelli T, Wutte M, Madl C, Weissel M.

Wien. Klin. Wochenschr. 2001; 113: 138-140.

 

The effects of ACE inhibitor therapy on left ventricular myocaardial mass and diastolic filling in previously untreated hypewrtensive patients: a cine MRI study.

Hoffmann U, Globits S, Stefenelli T, Loewe C, Kostner K, Frank H.

J. Magn. Reson. Imaging 2001; 14: 16-22.

 

Endothelial dysfunction in patients with polycythaemia vera.

Neunteufel T, Heher S, Stefenelli T, Pabinger I, Gisslinger H.

Br. J. Haematol. 2001; 115: 354-359.

 

Afterload reduction in severe aortic regurgitation.

Hoffmann U, Frank H, Stefenelli T, Kaiser B, Klaar U, Globits S.

J. Magn. Reson. Imaging 2001; 14: 693-697.

 

Contribution of nicotine to acute endothelial dysfunction in long-term smokers.

Neunteufl T, Heher S, Kostner K, Lehr S, Schmidt RW, Maurer G, Stefenelli T.

J. Am. Coll. Cardiol. 2002; 39: 251-6.

 

Prognostic impact of workload in patients with congestive heart failure.

Hülsmann M, Stefenelli T, Berger R, Frey B, PacherR.

Am. Heart J. 2002; 143: 308-12.

 

Intracoronary thrombectomy with the X-sizer catheter system improves epicardial flow and accelerates ST-segment resolution in patients with acute coronary syndrome: a prospective, randomized, controlled study.

Beran G, Lang I, Schreiber W, Denk S, Stefenelli T, Syeda B, Maurer G, Glogar D, Siostrzonek P.

Circulation 2002; 105: 2355-60.

 

Left ventricular echinococcosis with peripheral embolization.

Kopp CW, Binder T, Grimm M, Merl O, Thalhammer F, Ullrich R, Heinz G, Mundigler G, Stefenelli T, Maurer G, Baumgartner H, Zehetgruber M.

Circulation 2002; 106: 1741-2.

 

Predictors of early reangiography within 30 days after coronary stenting.

Scholten C, Schemper M, Probst P, Maurer G, Stefenelli T.

Can. J. Cardiol. 2003; 19: 1503-8.

 

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Pfeffer MA, McMurray, Velazquez EJ, Rouleau JL, Kober L, Maggioni AP, Solomon SD, Swedberg K, Van de Werft F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM; Valsartan in Acute Myocardial Infarction Trial Investigators.

N. Engl.J. Med. 2003;349:1893-906.

 

Erfolgreiche Lyse bei okklusiver Thrombose einer mechanischen Mitralklappenprothese.

Bracun R, Martys T, Ohnutek I, Stefenelli T.

J. Kardiol. 2004; 11: 474-7.

 

Atorvastatin reduces thrombin generation after percutaneous coronary intervention independent of soluble tissue factor.

Bartok A, Steiner S, Seidinger D, Jezl A, Huber K, Minar E, Stefenelli T, Kopp CW.

Thromb. Res. 2005; 115: 469-74.

 

Effect of radio contrast media on residual renal function in peritoneal dialysis patients a prospective study.

Dittrich E, Puttinger H, Schithuger M, Lang I, Stefenelli T, Hörl WH, Vychytil A.

Nephrol. Dial. Transplant. 2006;  5: 1334-9.

 

Repetitive Gabe von Levosimendan in verschiedenen Dosierungen bei schwerer chronischer Herzinsuffizienz.

Martys T, Martys R, Stefenelli T.

J. Kardiol. 2006; 13: 80-2.

 

Efficiacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.

Barrios V, Boccanelli A, Ewald S, Girerd X, Heagerty A, Krzesinski JM, Lins R, Rodicio J, Stefenelli T, Woittiez A, Böhm M.

Clin. Drug Investig. 2007; 27: 545-58.

 

Rationale and design of the multicentre randomized trial investigating the efficiacy and safety of pulsed infusions of levosimendan in outpatients with advanced heat failure (LevoRep study).

Altenberger J, Parissis JT, Ulmer H, Poelzl G; LevoRep Investigators.

Eur. J. Heart Fail. 2010; 12: 186-92.     

 

More efficient lifestyle modification and significant long-term increase in weight loss in the obese and performance from new treatment strategies.

Ohnutek I, Schrattenholzer E, Stefenelli T.

Wien. Klin. Wochenschr. 2010; 122: A44.

 

Effiziente Ernährungstherapie und signifikante langfristige Steigerung der Gewichtsreduktion bei Adipösen durch Verwendung eines Ernährungsrecalls.

Schrattenholzer E, Ohnutek I, Stefenelli T.

Aktuelle Ernährungsmed. 2010; 35. DOI:10.1055/s-0030-1254555.

 

Rationale and design oft he Soluble guanylate cyclase stimulator in heart failure studies (SOCRATES).

Pieske B, Butler J, Filippatos G, Lam C, Maggioni AP, Ponikowski R, Shah S, Solomon S, Kraugher.Krainer E, Samano ET, Scalise AV, Müller K, Roessig L, Gheorghiade ; SOCRATES Investigators and Coordinators.

Eur J. Heart Fail. 2014; 16: 1026-38.

 

One-year mortality in patients with ST-elevation myocardial infarction in the Vienna STEMI registry.

Jäger B, Farhan S, Kalla K, Glogar HD, Christ G, Karnuk R, Norman G, Prachar H, Schreiber W, Kaff A, Podczek-Schweighofer A, Weidinger F, Stefenelli T, Delle-Karth G, Laggner AN, Maurer G, Huber K; Vienna STEMI Registry Group.

Wien. Klin. Wochenschr. 2015;  127:  535-42.

 

Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: The SOCRATES-REDUCED randomized trial.

Gheorghiade M, Greene SJ, Butler J, Filippatos G, Lam CS, Maggioni AP, Ponikowski P, Shah SJ, Solomon SD, Kraigher-Krainer E, Samano ET, Müller K, Roessig L, Pieske B; SOCRATES-REDUCED Investigators and Coordinators.

JAMA 2015;  314:  2251-62.

 

Clinical predictors of patient related delay in the VIENNA ST-elevation myocardial infarction network and impact on long-term mortality.

Jäger B, Farhan S, Rohla M, Christ G, Podczeck-Schweighofer A, Schreiber W, Laggner AN, Weidinger F, Stefenelli T, Delle-Karth G, Kaff A, Maurer G, Huber K; Vienna STEMI Registry Group.

Eur. Heart J. Acute Cardiovasc. Care 2017;  6:  254-61.

 

Impact of time of admission on short- and long-term mortality in the Vienna STEMI registry.

Tscharre M, Jäger B, Farhan S, Christ G, Schreiber W, Weidinger F, Stefenelli T, Delle-Karth G,

Kaff A, Maurer G, Huber K; Vienna STEMI Registry Group.

Int. J. Cardiol. 2017; 244: 1-6. doi: 10.1016/j.ijcard.2017.03.029.

 

Gender differences in short- and long-term mortality in the Vienna STEMI registry.

Piackova E, Jäger B, Farhan S, Christ G, Schreiber W, Weidinger F, Stefenelli T, Delle-Karth G, Kaff A, Maurer G, Huber K; Vienna STEMI Registry Group.

Int. J. Cardiol. 2017; 244: 303-308. doi: 10.1016/j.ijcard.2017.05.068.

 

Disease management programs in chronic heart failure : Position statement of the Heart Failure Working Group and the Working Group of the Cardiological Assistance and Care Personnel of the Austrian Society of Cardiology.

Moertl D, Altenberger J, Bauer N, Berent R, Berger R, Boehmer A, Ebner C, Fritsch M, Geyrhofer F, Huelsmann M, Poelzl G, Stefenelli T.

Wien. Klin. Wochenschr. 2017; 129:  869-78.

 

Impact of age on short- and long-term mortality of patients with ST-elevation myocardial infarction in the VIENNA STEMI network.

Haller PM, Jäger B, Farhan S, Christ G, Schreiber W, Weidinger F, Stefenelli T, Delle-Karth G, Kaff A, Maurer G, Huber K.

Wien. Klin. Wochenschr. 2018; 130: 172-81.